New LaunchJun 10, 2026, 06:31 AM
Tilray Launches ARX Premium Medical Cannabis Brand in Germany
AI Summary
Tilray Medical Germany, a division of Tilray Brands, Inc., announced the launch of ARX™, its first premium medical cannabis brand developed and cultivated in Germany. The brand, which debuts at Mary Jane Berlin 2026, is the result of over two years of development at the Aphria RX facility in Neumünster. ARX aims to provide consistent, high-quality medical cannabis products to patients and healthcare professionals, leveraging genetics from Broken Coast and Tilray's established German infrastructure for national distribution. This launch strengthens Tilray's position in the evolving German medical cannabis market.
Key Highlights
- Tilray Medical Germany launched ARX™, its first premium medical cannabis brand cultivated in Germany.
- ARX was developed over two years at the Aphria RX facility in Neumünster.
- The brand utilizes genetics sourced from Broken Coast's renowned library.
- Production adheres to strict EU-GMP standards at the Aphria RX facility.
- National distribution in Germany will be handled by CC Pharma and 14U Pharma.
- ARX will officially debut at Mary Jane Berlin 2026.
Price Impact
More from TLRY